...
首页> 外文期刊>Pharmaceutical research >The use of nano polymeric self-assemblies based on novel amphiphilic polymers for oral hydrophobic drug delivery.
【24h】

The use of nano polymeric self-assemblies based on novel amphiphilic polymers for oral hydrophobic drug delivery.

机译:基于新型两亲聚合物的纳米聚合物自组装体用于口服疏水性药物递送的用途。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

To investigate the use of nano self-assemblies formed by polyallylamine (PAA) modified with 5 or 10% mole fluorenylmethoxy carbonyl (Fmoc(5)/(10)), dimethylamino-1-naphthalenesulfonyl (Dansyl(5)/(10)) and 5% mole cholesteryl group (Ch(5)) for oral hydrophobic drug delivery.Propofol, griseofulvin and prednisolone were loaded into amphiphilic PAAs. Particle size and morphology of drug-loaded self-assemblies were determined using photon correlation spectroscopy and transmission electron microscopy. Solubilising capacity, in vitro drug release and formulation stability were analysed by HPLC, and in vitro biocompatibility studies (haemolysis and cytotoxicity) were carried out on bovine erythrocytes and Caco-2 cells, respectively. Dansyl(10) and Ch(5) griseofulvin formulations were administered intra-gastrically to rats, and drug plasma levels were analysed by HPLC.Drug-encapsulated self-assemblies typically have hydrodynamic size of 300-400?nm. Dansyl(10) exhibited universal drug solubiliser property and had significantly improved prednisolone, griseofulvin and propofol solubility by 145, 557 and 224-fold, respectively. Fmoc polymers resulted in modest drug solubility improvement. These polymers were non-haemolytic, did not enhance cytotoxicity compared to unmodified PAA, and demonstrated significant increase in griseofulvin plasma concentration compared to griseofulvin in water after oral administration.Ch(5) and Dansyl(10) showed promising potential as nano-carriers for oral hydrophobic drug delivery.
机译:研究使用由5%或10%摩尔芴基甲氧基羰基(Fmoc(5)/(10)),二甲基氨基-1-萘磺酰基(Dansyl(5)/(10))改性的聚烯丙胺(PAA)形成的纳米自组装体的用途和5%摩尔胆固醇基(Ch(5))用于口服疏水药物递送。将异丙酚,灰黄霉素和泼尼松龙装入两亲PAA中。使用光子相关光谱法和透射电子显微镜确定载药自组装体的粒径和形态。通过HPLC分析其溶解能力,体外药物释放和制剂稳定性,并且分别对牛红细胞和Caco-2细胞进行了体外生物相容性研究(溶血和细胞毒性)。胃内给予Dansyl(10)和Ch(5)灰黄霉素制剂,并通过HPLC分析药物血浆水平。药物包裹的自组装体的流体动力学大小通常为300-400?nm。 Dansyl(10)表现出通用的药物增溶剂性能,并且泼尼松龙,灰黄霉素和丙泊酚的溶解度分别显着提高了145、557和224倍。 Fmoc聚合物导致适度的药物溶解性改善。与未修饰的PAA相比,这些聚合物具有非溶血性,没有增强细胞毒性,并且口服后与水中的灰黄霉素相比,其灰黄霉素的血浆浓度显着增加.Ch(5)和Dansyl(10)显示出有望用作纳米载体的潜力口服疏水性药物传递。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号